As 2025 drew to a close, the Centers for Medicare & Medicaid Services (“CMS”) issued proposed rules for two mandatory pricing models aiming to reduce out-of-pocket costs for Medicare drugs. The ...

A bipartisan bill (HB 483), meant to curb pharmaceutical drug prices in the name of affordability, was recently vetoed by ...

WASHINGTON, March 24, 2026 /PRNewswire/ -- The Rare Access Action Project (RAAP) today announced the release of a new policy paper, "Importing Most Favored Nation Pricing into States Is Not the Answer ...

During the first year of his second term, President Trump has issued 228 executive orders. That is more executive orders than every other president has issued over any four-year term. Sound policy is ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. President Trump during an announcement in the Roosevelt Room of the White House in ...

The U.S. Centers for Medicare & Medicaid Services has extended application deadlines for its Medicaid drug pricing model, giving drugmakers and states more time to participate in the effort to align ...

The three largest pharmacy benefit managers — Caremark, Express Scripts and Optum Rx — each excluded more than 600 drugs from their 2026 formularies, reflecting shifts in drug pricing models that are ...

Drug pricing in 2026 is being reshaped at the pharmacy counter, in federal agencies and in courtrooms — all at once. Within a single month, CMS finalized another round of Medicare price cuts affecting ...

The U.S. Centers for Medicare & Medicaid Services has pushed back application and agreement deadlines for its Medicaid drug pricing model, allowing drugmakers and states more preparation time. Pfizer ...